Impairment of JCV-specific T-cell response by corticotherapy

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Impairment of JCV-specific T-cell response by corticotherapy

Postby MSUK » Wed Dec 05, 2012 2:11 am

Impairment of JCV-specific T-cell response by corticotherapy: Effect on PML-IRIS management?


Summary: This study from Switzerland examined the net effects of corticosteroids (CS) on the virus-specific T-cell responses, especially JC virus, to determine the optimal timing of corticosteroid administration in patients with MS with natalizumab-caused progressive multifocal leucoencephalopathy-immune reconstitution inflammatory syndrome (PML-IRIS).

The results showed that CS led T cells, either CD4+ or Cd8+, towards a less differentiated phenotype. There was a significant decrease in the proliferation of EBV-, influenza- and JCV-specific T–cell proliferation response upon CS treatment. CS significantly decreased the proliferation of all three virus-specific CD4+ T cells. CS also caused a significant decrease in cytokine production of CD8+ T cells only when these cells were stimulated by JCV, but not EBV or influenza.

Therefore, CS have a significant effect on the virus-specific T-cell response, in particular on JCV, and it is suggested that giving CS before there are signs of immune reconstitution, may be deleterious as such treatment may blunt the JCV-specific T-cell response, leading to the unopposed progression of PML with grim consequences.

When CS are considered, there is conclusive rational to give CS only when the patient shows the first clinical or MRI signs of IRIS. Studies directly addressing patients with MS with natalizumab-caused PML are warranted.... Read More - ... ageid/3406
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Return to General Discussion


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service